TABLE 14: Treatment - chemotherapy

% of Cases treated with Chemotherapy
Country average (population) Country average (country) England Scotland Northern Ireland Wales Republic of Ireland
All invasive xnmsc 26.6% 26.7% 26.6% 25.5% 28.0%
All xnmsc 0-24 59.2% 60.1% 59.4% 54.5% 66.3%
All xnmsc 25-59 40.0% 41.2% 39.8% 41.3% 42.5%
All xnmsc 60-79 27.3% 26.7% 27.6% 25.3% 27.3%
All xnmsc 80+ 8.4% 8.2% 8.6% 6.1% 9.9%
Haematology 53.0% 55.8% 52.6% 55.0% 59.9%
Head and Neck 30.0% 25.2% 31.1% 23.6% 20.8%
Lower GI 32.4% 31.0% 32.6% 31.2% 29.3%
Upper GI 39.9% 40.9% 40.1% 37.0% 45.7%
HPB 23.6% 23.9% 24.0% 17.6% 30.0%
Trachea, Bronchus & Lung 27.1% 24.3% 27.9% 21.5% 23.5%
Melanoma of skin 1.4% 2.1% 1.4% 0.1% 4.8%
Breast 32.4% 34.5% 32.2% 31.5% 39.9%
Cervix 37.5% 41.1% 36.7% 41.6% 45.1%
Other Female Genitals 30.1% 32.4% 29.6% 34.7% 32.9%
Prostate 6.2% 6.7% 6.0% 8.5% 5.6%
Kidney 8.1% 6.8% 8.5% 2.5% 9.4%
Bladder 29.3% 26.4% 29.7% 27.9% 21.7%
Brain and CNS 30.2% 31.3% 30.0% 31.4% 32.6%
Thyroid & other endocrine glands 4.5% 3.2% 4.7% 3.1% 1.9%
CUP 11.8% 10.5% 12.1% 9.1% 10.2%
Other invasive cancer 29.3% 28.5% 29.6% 26.9% 29.1%
Breast in situ 1.8% 1.6% 1.9% 0.9% 2.0%
Cervix in situ 0.0% 0.0% 0.0% 0.0% 0.1%
Other tumours 12.6% 11.3% 13.0% 12.6% 8.3%
Non-Melanoma Skin Cancer 0.2% 0.5% 0.1% 0.7% 0.8%